{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:53:39Z","timestamp":1775818419314,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Because activation of the alternative pathway (AP) of the complement system is an important aspect of both age-related macular degeneration (AMD) and rheumatoid arthritis (RA), we wished to address the question whether genetic risk factors of the AP inhibitor complement factor H (CFH) for AMD would also be risk factors for RA. For this purpose we genotyped single nucleotide polymorphisms (SNPs) in a Dutch set of RA patients and controls. Similarly, a meta-analysis using a Spanish cohort of RA as well as six large genome-wide association studies (GWAS) studies was performed. For these SNPs we analysed more than 6000 patients and 20 000 controls. The CFH variants, I62V, Y402H, IVS1 and IVS10, known to associate strongly with AMD, did not show a significant association with the risk of developing RA despite a strong statistical power to detect such differences. In conclusion, the major risk alleles of AMD in CFH do not have a similar effect on developing RA.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04482.x","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T22:38:35Z","timestamp":1316212715000},"page":"333-337","source":"Crossref","is-referenced-by-count":10,"title":["The major risk alleles of age-related macular degeneration (AMD) in <i>CFH<\/i> do not play a major role in rheumatoid arthritis (RA)"],"prefix":"10.1093","volume":"166","author":[{"given":"L A","family":"Trouw","sequence":"first","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"B\u00f6hringer","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N A","family":"Daha","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Stahl","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Raychaudhuri","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A","family":"Kurreeman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"},{"name":"Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Stoeken-Rijsbergen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Houwing-Duistermaat","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T W","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R E","family":"Toes","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"2021122708465472200_b1","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMra062326","article-title":"Age-related macular degeneration","volume":"355","author":"de Jong","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122708465472200_b2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"2021122708465472200_b3","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708465472200_b4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"2021122708465472200_b5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122708465472200_b6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet"},{"key":"2021122708465472200_b7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"Sjoberg","year":"2009","journal-title":"Trends Immunol"},{"key":"2021122708465472200_b8","doi-asserted-by":"crossref","first-page":"30192","DOI":"10.1074\/jbc.M110.103986","article-title":"Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina","volume":"285","author":"Clark","year":"2010","journal-title":"J Biol Chem"},{"key":"2021122708465472200_b9","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.178.6.3831","article-title":"Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein","volume":"178","author":"Laine","year":"2007","journal-title":"J Immunol"},{"key":"2021122708465472200_b10","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1074\/jbc.M610256200","article-title":"The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells","volume":"282","author":"Sjoberg","year":"2007","journal-title":"J Biol Chem"},{"key":"2021122708465472200_b11","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.molimm.2007.02.012","article-title":"Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration","volume":"44","author":"Skerka","year":"2007","journal-title":"Mol Immunol"},{"key":"2021122708465472200_b12","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.4049\/jimmunol.175.9.5575","article-title":"The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis","volume":"175","author":"van Gaalen","year":"2005","journal-title":"J Immunol"},{"key":"2021122708465472200_b13","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.177.3.1904","article-title":"Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis","volume":"177","author":"Banda","year":"2006","journal-title":"J Immunol"},{"key":"2021122708465472200_b14","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.179.6.4101","article-title":"Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway","volume":"179","author":"Banda","year":"2007","journal-title":"J Immunol"},{"key":"2021122708465472200_b15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"2021122708465472200_b16","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021122708465472200_b17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.molimm.2011.04.024","article-title":"Complement activation by (auto-)antibodies","volume":"48","author":"Daha","year":"2011","journal-title":"Mol Immunol"},{"key":"2021122708465472200_b18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/07853890701477546","article-title":"Rheumatoid arthritis and the complement system","volume":"39","author":"Okroj","year":"2007","journal-title":"Ann Med"},{"key":"2021122708465472200_b19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/39.2.189","article-title":"Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis","volume":"39","author":"Aggarwal","year":"2000","journal-title":"Rheumatology (Oxf)"},{"key":"2021122708465472200_b20","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1371\/journal.pmed.0040278","article-title":"A candidate gene approach identifies the TRAF1\/C5 region as a risk factor for rheumatoid arthritis","volume":"4","author":"Kurreeman","year":"2007","journal-title":"PLoS Med"},{"key":"2021122708465472200_b21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3899\/jrheum.090022","article-title":"Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA","volume":"36","author":"Dieguez-Gonzalez","year":"2009","journal-title":"J Rheumatol"},{"key":"2021122708465472200_b22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat Genet"},{"key":"2021122708465472200_b23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat Genet"},{"key":"2021122708465472200_b24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/321275","article-title":"Linkage disequilibrium in humans: models and data","volume":"69","author":"Pritchard","year":"2001","journal-title":"Am J Hum Genet"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04482.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/166\/3\/333\/41908555\/j.1365-2249.2011.04482.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/166\/3\/333\/41908555\/j.1365-2249.2011.04482.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:18:38Z","timestamp":1641053918000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/166\/3\/333\/6423030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,11,8]]},"published-print":{"date-parts":[[2011,11,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04482.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,11,8]]}}}